Browse By Region
Browse By Category
Recent News
By Category: Research
Double dose of antiviral drug offers no added benefit in severe influenza
(EurekAlert) Giving double doses of the antiviral drug oseltamivir, or Tamiflu, offers no clinical or virological advantages over a standard dose for patients admitted to hospital with severe influenza infection, according to a randomised trial published today and funded by the Wellcome Trust, US National Institute of Allergy and Infectious Diseases and the Singapore National Read More »
- May 31, 2013
- | Filed under North America, Agents & Toxins, Public Health, and Research
- Share
-
FDA Lifts Clinical Hold On PharmAthene’s SparVax(R) Anthrax Vaccine Program
(TheWallStreetJournal) PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold previously placed on a proposed Phase II study of SparVax(R) , a next generation recombinant anthrax vaccine. “We are very pleased by the Read More »
- May 31, 2013
- | Filed under North America, Agents & Toxins, Biological Weapons, Bioterrorism, Countermeasures, Public Health, and Research
- Share
-
Experts Call For Increased Monitoring Of Drug Resistant Bird Flu
(MedicalNewsToday) Drug resistance was detected in more than half of human H5N1 viruses in a new study published in the journal Antiviral Research, causing experts to call for increased monitoring of the bird flu. Highly pathogenic influenza viruses (H5N1) mostly impact birds but can sometimes cross the species barrier and infect people. H5N1 flu outbreaks Read More »
- May 30, 2013
- | Filed under Asia/Pacific, North America, Agents & Toxins, International, Policy & Initiatives, Public Health, and Research
- Share
-
Ebola’s secret weapon revealed
(VirtualMedicalCentre) Researchers have discovered the mechanism behind one of the Ebola virus’ most dangerous attributes: its ability to disarm the adaptive immune system. University of Texas Medical Branch at Galveston scientists determined that Ebola short-circuits the immune system using proteins that work together to shut down cellular signaling related to interferon. Disruption of this activity, Read More »
- May 30, 2013
- | Filed under Africa, North America, Agents & Toxins, International, Public Health, and Research
- Share
-
MRSA study slashes deadly infections in sickest hospital patients
(CDC) Using germ-killing soap and ointment on all intensive-care unit (ICU) patients can reduce bloodstream infections by up to 44 percent and significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in ICUs. A new Department of Health and Human Services-funded study released today tested three MRSA prevention strategies and found that using germ-killing soap Read More »
- May 30, 2013
- | Filed under North America, Agents & Toxins, Public Health, and Research
- Share
-
